Drugs preventing Na+ and Ca2+ overload

Pharmacological Research

Volumn 39, Issue 3, 1999, Pages 167-174

  Ravens, Ursula ^a   Himmel, Herbert M ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Na+, Ca2+ exchanger; Na+, H+ exchanger, hypoxia, ischaemia; Na+, K+ ATPase; Reperfusion, arrhythmias

Indexed keywords

2 (3,5 DI TERT BUTYL 4 HYDROXYPHENYL) 3 [3 [N METHYL N [2 (3,4 METHYLENEDIOXYPHENOXY)ETHYL]AMINO]PROPYL] 4 THIAZOLIDINONE; 4 [3 (4 BENZHYDRYL 1 PIPERAZINYL) 2 HYDROXYPROPOXY] 1H INDOLE 2 CARBONITRILE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BENZOTHIAZOLE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; CARIPORIDE; DIGITALIS; ION CHANNEL; N [1 [4 (4 FLUOROPHENOXY)BUTYL] 4 PIPERIDINYL] N METHYL 2 BENZOTHIAZOLAMINE; SODIUM CHANNEL BLOCKING AGENT; SODIUM CHANNEL STIMULATING AGENT; SODIUM ION; VERATRIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CALCIUM CELL LEVEL; CALCIUM CURRENT; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; HEART ARRHYTHMIA; HEART CONTRACTION; HEART DISEASE; HEART PROTECTION; HEART VENTRICLE FIBRILLATION; HUMAN; ION CURRENT; ION EXCHANGE; ION TRANSPORT; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTON SODIUM EXCHANGE; REVIEW; SODIUM CELL LEVEL; SODIUM TRANSPORT;

EID: 0033106246     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1998.0416     Document Type: Article

References (50)

1. Bers DM. Excitation-contraction Coupling and Cardiac Contractile Force. Dordrecht/Boston/London: Kluwer Academic Publishers, 1991.
2. Ravens U, Wettwer E. Modulation of sodium/calcium exchange: A hypothetical positive inotropic mechanism. J Cardiovasc Pharmacol 1989; 14(suppl 3): S30-5.
3. i during caffeine contractures in rabbit cardiomyocytes. J Physiol (London) 1992; 453: 581-608.
4. 2+] transient, membrane potential, and contraction. J Gen Physiol 1984; 86: 395-415.
5. Akera T, Brody TM. The role of the Na,K-ATPase in the inotropic action of digitalis. Pharmacol Rev 1978; 29: 187-220.
6. Eisner DA, Smith TW. The Na-K pump and its effectors in cardiac muscle. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. The Heart and Cardiovascular System, 2nd Ed. New York: Raven Press, 1992: 863-902.
7. Kass RS, Lederer WJ, Tsien RW, Weingart R. Role of calcium ions in transient inward currents and aftercontractions induced by strophathidin in cardiac Purkinje fibres. J Physiol (London) 1978; 281: 187-208.
8. Kimura J. Na-Ca exchange and Ca-sensitive non-selective cation current components of transient inward current in isolated cardiac ventricular cells of the guinea-pig. J Physiol (London) 1988; 407: 79P.
9. + current in cardiac cells: Rectification, open probability, block and role in digitalis toxicity. Pflügers Arch 1990; 416: 766-9.
10. + in single cardiac Purkinje cells. Am J Physiol 1989; 256: C1086-92.
11. Honerjäger P. Cardioactive substances that prolong the open state of the sodium channels. Rev Physiol Biochem Pharmacol 1982; 92: 1-74.
12. Buggisch D, Isenberg G, Ravens U, Scholtysik G. The role of sodium channels in the effects of the cardiotonic compound DPI 201-106 on contractility and membrane potentials in isolated mammalian heart preparations. Eur J Pharmacol 1985; 118: 303-11.
13. Ju YK, Saint DA, Gage PM. Hypoxia increases persistent sodium current in rat ventricular myocytes. J Physiol (London) 1996; 497: 337-47.
14. Guarnieri T. Intracellular sodium-calcium dissociation in early contractile failure in hypoxic ferret papillary muscles. J Physiol (London) 1987; 388: 449-65.
15. 23Na-NMR measurements of intracellular sodium in intact perfused ferret hearts during ischemia and reperfusion. Am J Physiol 1990; 259: H1767-73.
16. 2+ exchange. Circ Res 1989; 65: 1045-56.
17. + exchange in cardiac physiology and pathophysiology: Mediation of myocardial reperfusion injury by the pH paradox. Cardiovasc Res 1993; 27: 915-24.
18. + exchange. Am J Physiol 1993; 265: H2017-26.
19. Lazdunski M, Freiin C, Vigne P. The sodium/hydrogen exchange system in cardiac cells: Its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J Mol Cell Cardiol 1985; 17: 1029-42.
20. + channel of guinea-pig ventricular cell membrane. Pflügers Arch 1992; 422: 280-6.
21. e changes during ischemia in rat heart. Am J Physiol 1992; 263: H333-40.
22. Koch P, Wilffert B, Peters T. R 56865: A new anti-ischemic principle. Cardiovasc Drug Rev 1990; 8: 238-54.
23. Ver Donck L, Borgers M. Myocardial protection by R 56865: A new principle based on prevention of ion channel pathology. Am J Physiol 1991; 261: H1828-35.
24. Wilhelm D, Himmel H, Ravens U, Peters T. Characterization of the interaction of R 56865 with cardiac Na- and L-type Ca channels. Br J Pharmacol 1991; 104: 483-9.
25. Vollmer B, Meuter C, Janssen PA. R 56865 prevents electrical and mechanical signs of ouabain intoxication in guinea-pig papillary muscle. Eur J Pharmacol 1987; 142: 137-40.
26. Finet M, Bravo G, Godfraind T. The protective action of R56865 against ouabain-induced intoxication in rat heart isolated atria and ventricles. Eur J Pharmacol 1989; 164: 555-63.
27. 2+ overload with R56865 protects against cardiac arrhythmias elicited by ouabain in vivo in guinea-pigs. Eur J Pharmacol 1993; 235: 89-93.
28. Heers C, Scheufler E, Wilhelm D, Wermelskirchen D, Wilffert B, Peters T. Differential effect of R 56865 on ouabain binding to isolated sarcolemma and intact atrial tissue of guinea-pig. Br J Pharmacol 1991; 102: 675-8.
29. Himmel HM, Wilhelm D, Ravens U. Effects of R56865 on membrane currents in isolated ventricular cardiomyocytes of the guinea-pig. Eur J Pharmacol 1990; 187: 235-40.
30. Leyssens A, Carmeliet E. Block of the transient inward current by R56865 in guinea-pig ventricular myocytes. Eur J Pharmacol 1991: 196: 43-51.
31. + channel in cardiac cells. Eur J Pharmacol 1991; 196: 53-60.
32. + current by R56865 in single cardiac Purkinje cells. Eur J Pharmacol 1991; 203: 371-8.
33. Haigney MCP, Lakatta EG, Stern MD, Silverman HS. Sodium channel blockade reduces hypoxic sodium loading and sodium-dependent calcium loading. Circulation 1994; 90: 391-9.
34. + current blockers. Am J Physiol 1995; 269: H533-40.
35. 2+ release from SR in cardiac myocytes. Am J Physiol 1994; 266: H511-20.
36. McGarry GJ, Scheufler E, Williams AJ. Effect of R56865 on cardiac sarcoplasmic reticulum function and its role as an antagonist of digoxin at the sarcoplasmic reticulum calcium release channel. Br J Pharmacol 1995; 114: 231-7.
37. Chu A, Diaz-Munoz M, Hawkes MJ, Brush K, Hamilton SL. Ryanodine as a probe for the functional state of the skeletal muscle sarcoplasmic reticulum calcium release channel. Mol Pharmacol 1991; 37: 735-41.
38. Garner JA, Hearse DJ, Bernier M. R56865, a potent new antiarrhythmic agent, effective during ischemia and reperfusion in the rat heart. J Cardiovasc Pharmacol 1990; 16: 468-79.
39. Vos MA, van Deursen RTAM, Gorgels APM, Leunissen JDM, Wellens HJJ. R56865, an antiarrhythmic drug with class III effects that terminates ouabain induced ventricular tachycardia in an inverse rate dependent manner. Cardiovasc Res 1993; 27: 1491-7.
40. 2+ overload in cardiomyocytes and mechanical activities in vascular strips. Eur J Pharmacol 1996; 312: 195-202.
41. Koga T, Fukazawa M, Suzuki Y, Akima M, Adachi Y, Tamura K, Kato T, Kuromaru O. The protective effects of CP-060S on ischaemia- and reperfusion-induced arrhythmias in anaesthetized rats. Br J Pharmacol 1998; 123: 1409-17.
42. Karmazyn M. The sodium-hydrogen exchange system in the heart: Its role in ischemic and reperfusion injury and therapeutic implications. Can J Cardiol 1996; 12: 1074-82.
43. + antiporter isoforms using amiloride analogs and a new inhibitor exhibiting anti-ischemic properties. Mol Pharmacol 1993; 44: 1041-5.
44. + exchange inhibitor and its effects in cardiac ischaemia. Br J Pharmacol 1993; 109: 562-8.
45. Scholz W, Albus U, Counillon I, Gögelein H, Lang H-J, Linz W, Weichert A, Schölkens BA. Protective effects of Hoe642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion. Cardiovasc Res 1995; 29: 260-8.
46. +-exchange inhibitor cariporide (Hoe 642) on cardiac tissue. Naunyn-Schmiedeberg's Arch Pharmacol 1998; 357: 662-70.
47. 2+ overload in isolated perfused rabbit heart. Circulation 1994; 89: 2787-98.
48. + exchanger activity does not contribute to protection by ischemic preconditioning in the isolated rat heart. Circulation 1997; 96: 3617-25.
49. Duff HJ, Mitchell LB, Kavanagh KM, Manyari DE, Gillis AM, Wyse DG. Amiloride: Antiarrhythmic and electrophysiologic actions in patients with inducible sustained ventricular tachycardia. Circulation 1989; 79: 1257-63.
50. Duff HJ. Clinical and in vivo antiarrhythmic potential of sodium-hydrogen exchange inhibitors. Cardiovasc Res 1995; 29: 189-93.